brodalumab
brodalumab is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: injection.
Drug Details
- Generic Name
- brodalumab
- Brand Names
- N/A
- Application Number
- Sponsor
- Patheon Italia S.p.A.
- NDC Codes
- 1
- Dosage Forms
- INJECTION
- Routes
- N/A
- Active Ingredients
- BRODALUMAB
Indications and Usage
1 INDICATIONS AND USAGE SILIQ ® (brodalumab) is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. SILIQ is a human interleukin-17 receptor A (IL-17RA) antagonist indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies. ( 1 )